Trials / Conditions / Secondary Hemophagocytic Lymphohistiocytosis

Secondary Hemophagocytic Lymphohistiocytosis

5 registered clinical trials studyying Secondary Hemophagocytic Lymphohistiocytosis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE St NCT06339177	National Institute of Allergy and Infectious Diseases (NIAID)	—
Completed	Efficacy and Safety of Interferon-Gamma Monoclonal Antibody Combined With Dexamethasone in the Treatment of Re NCT07531069	Fudan University	—
Unknown	Prospective Study of Immune Function and PD-1 Antibody Therapy Efficacy Predictors on CAEBV and EBV-HLH Patien NCT05841342	Beijing Friendship Hospital	—
Unknown	Rituximab Monotherapy for EBV-HLH and CAEBV NCT05384743	Beijing Friendship Hospital	Phase 3
Completed	Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's NCT05001737	Swedish Orphan Biovitrum	Phase 3